ESMO Symposium on Signalling Pathways in Cancer - Targeting the PI3K / AKT / mTOR Pathway in Cancer
Symposium - Sitges, Barcelona, Spain
Building on the success of 2013, the second ESMO Symposium on Signalling Pathways in Cancer will focus on the PI3K/AKT/mTOR pathway. The programme has been designed provide oncology professionals with the latest scientific developments behind molecular pathways in cancer and a personalised approach to cancer treatment.
This unique oncology meeting brings together academic, clinical and industry researchers, practicing and young oncologists – all stakeholders working in different tumour settings but sharing common underlining mechanisms and signalling pathways.
Organization: ESMO
(Courtesy of logo of European Society for Medical Oncology, via www.nature.com)
ESMO Symposium on Signalling Pathways in Cancer - Targeting the PI3K / AKT / mTOR Pathway in Cancer
Fri, Feb 28, 2014 - Sat, Mar 01, 2014
Hotel Malia Sitges
Sitges, Barcelona, Spain
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
